Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation

Journal of Cardiothoracic Surgery

Volumn 5, Issue 1, 2010, Pages

  Parissis, Haralabos ^a   Gould, Kate ^b   Dark, John ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MACROLIDE; TACROLIMUS;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; LUNG EMPHYSEMA; LUNG TRANSPLANTATION; MIDDLE AGED;

DRUG INTERACTIONS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MACROLIDES; MIDDLE AGED; PULMONARY EMPHYSEMA; TACROLIMUS;

EID: 77956492346     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-5-70     Document Type: Article

References (15)

1. Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 2003, 63(12):1247-97. 10.2165/00003495-200363120-00006, 12790696.
2. Reichenspurner H. Overview of tacrolimus-based immunosuppression after heart or lung transplantation. J Heart Lung Transplant 2005, 24(2):119-30. 10.1016/j.healun.2004.02.022, 15701425.
3. Keogh A. Calcineurin inhibitors in heart transplantation. J Heart Lung Transplant 2004, 23(5 Suppl):S202-6. 10.1016/j.healun.2004.03.008, 15093806.
4. Fan Y, Xiao YB, Weng YG. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. Transplant Proc 2009, 41(5):1821-4. 10.1016/j.transproceed.2008.11.016, 19545736.
5. Moake J. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Pract Res Clin Haematol 2009, 22(4):567-76. 10.1016/j.beha.2009.07.004, 19959109.
6. Singh N, Gayowski T, Marino IR. Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int 1996, 9(1):68-75. 10.1111/j.1432-2277.1996.tb00855.x, 8748414.
7. Schmidt RJ, Venkat KK, Dumler F. Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. Transplant Proc 1991, 23(6):3156-7.
8. Lin CC, King KL, Chao YW, Yang AH, Chang CF, Yang WC. Tacrolimus-associated hemolytic uremic syndrome: a case analysis. J Nephrol 2003, 16(4):580-5.
9. Trimarchi HM, Truong LD, Brennan S, Gonzalez JM, Suki WN. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. Transplantation 1999, 27;67(4):539-44.
10. Pham PT, Peng A, Wilkinson AH, Gritsch HA, Lassman C, Pham PC, Danovitch GM. Cyclosporine and tacrolimus-associated thrombotic microangiopathy. Am J Kidney Dis 2000, 36(4):844-50.
11. Myers JN, Shabshab SF, Burton NA, Nathan SD. Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome. J Heart Lung Transplant 1999, 18(10):1024-6. 10.1016/S1053-2498(99)00056-X, 10561115.
12. Shitrit D, Starobin D, Aravot D, Fink G, Izbicki G, Kramer M. Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient. Transplant Proc 2003, 35(2):627-8. 10.1016/S0041-1345(03)00015-0, 12644073.
13. Boctor FN. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin. Egypt J Immunol 2006, 13(2):95-9.
14. Mercadal L, Petitclerc T, Assogba U, Beaufils H, Deray G. Hemolytic and uremic syndrome after heart transplantation. Am J Nephrol 2000, 20(5):418-20. 10.1159/000013629, 11093002.
15. Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, DeMarco T. Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient. J Heart Lung Transplant 1993, 12(3):440-4.